Automation, miniaturization, and new software algorithms are improving throughput and accuracy. High-throughput screening (HTS) enables the rapid testing of numerous compounds against biological ...

The FDA’s emerging framework represents more than a regulatory update; it is a paradigm shift toward human-relevant, ...

A rare moment of bipartisan progress has emerged with the Senate’s unanimous passage of the FDA Modernization Act 3.0, ...

Microphysiological systems help address the shortcomings of animal models for mAb development, and CN Bio is taking an active role in supporting organizations in switching to an NAMs-based approach.

Although it is sometimes thought that quality assurance (QA) and software testing are the same, they are, in fact, different concepts. They differ in their objectives, features and methods. Testers ...

The FDA is moving away from requiring animal models for investigational new drug (IND) applications for new monoclonal antibodies and some other drug candidates. Animal testing will be "reduced, ...

In April 2025, the U.S. Food and Drug Administration (FDA) released its Roadmap to Reducing Animal Testing in Preclinical Safety Studies—a landmark initiative that lays out a plan to make animal ...

Abrasion testing is a necessity for manufacturers who are interested in producing high-quality products with a long lifespan. With a multitude to different testing methods available, each with their ...